Document is current
Any future updates will be listed below
-
Authors
Schlosser, Marco https://orcid.org/0000-0002-0634-0749
Barnhofer, Thorsten
Requier, Florence
Deza-Araujo, Yacila I.
Abdoun, Oussama
Marchant, Natalie L.
Chételat, Gaël
Collette, Fabienne
Klimecki, Olga M.
Lutz, Antoine https://orcid.org/0000-0002-0258-3233
,
André, Claire
Ashton, Nicholas
Allais, Florence
Asselineau, Julien
Arenaza-Urquijo, Eider
Bachelet, Romain
Baez, Sebastian
Batchelor, Martine
Beaugonin, Axel
Belleoud, Viviane
Benson, Clara
Bosch, Beatriz
Botton, Maelle
Casanova, Maria Pilar
Champetier, Pierre
Chocat, Anne
Coll, Nina
Dautricourt, Sophie
Delamillieure, Pascal
De La Sayette, Vincent
Delarue, Marion
Demnitz-King, Harriet
Dolma, Titi
Egret, Stéphanie
Felisatti, Francesca
Ferrand-Devouges, Eglantine
Frison, Eric
Gheysen, Francis
Goldet, Karine
Gonneaud, Julie
Hye, Abdul
Philippe, Agathe Joret
Kuhn, Elizabeth
Landeau, Brigitte
Ledu, Gwendoline
Lefranc, Valérie
Leon, Maria
Meiberth, Dix
Mezenge, Florence
Milz, Ester
Moulinet, Inès
Mueller, Hendrik
Mueller, Theresa
Ourry, Valentin
Palix, Cassandre
Paly, Léo
Poisnel, Géraldine
Quillard, Anne
Ramirez, Alfredo
Rauchs, Géraldine
Reyrolle, Leslie
Salinero, Ana
Salmon, Eric
Sannemann, Lena
Satgunasingam, Yamna
Schwimmer, Christine
Steinhauser, Hilde
Touron, Edelweiss
Vivien, Denis
Vuilleumier, Patrik
Wallet, Cédrick
Whitfield, Tim
Wingrove, Janet
-
Funding
Funding for this research was provided by:
Horizon 2020 (667696)
European Research Council Consolidator Grant (617739)
- License Information
-
More Information
Article History
Accepted: 13 December 2021
First Online: 31 January 2022
Declarations
:
: GC has received research support from the EU’s Horizon 2020 Research and Innovation Programme (grant agreement number 667696), Inserm, Fondation d’entreprise MMA des Entrepreneurs du Futur, Fondation Alzheimer, Programme Hospitalier de Recherche Clinique, Région Normandie, Association France Alzheimer et maladies apparentées and Fondation Vaincre Alzheimer (all to Inserm), and personal fees from Fondation d’entreprise MMA des Entrepreneurs du Futur. All other authors have no relevant financial or non-financial interests to disclose.
: Written informed consent was obtained from all participants after the procedures had been explained to them and prior to participation. The Age-Well trial received ethics approval from the Comité de Protection des Personnes CPP Nord-Ouest III in Caen (trial registration number: EudraCT 2016–002441-36). The multi-centre SCD-Well trial received ethics approval from the committees and regulatory agencies of all centres: London, UK (Queen Square Research Ethics Committee: No. 17/LO/0056 and Health Research Authority National Health Service, IRAS project ID: 213008); Lyon, France (Comité de Protection des Personnes Sud-Est II Groupement Hospitalier Est: No. 2016–30-1 and Agence Nationale de Sécurité du Médicament et des Produits de Santé: IDRCB 2016-A01298-43); Cologne, Germany (Ethikkommission der Medizinischen Fakultät der Universität zu Köln: No. 17–059); and Barcelona, Spain (Comité Etico de Investigacion Clinica del Hospital Clinic de Barcelona: No. HCB/2017/0062). The Brain & Mindfulness project received ethics approval from the Comité de Protection des Personnes CPP Sud-Est IV in Lyon (No. 2015-A01472-47). All studies have been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
